Compare Reddit Inc (RDDT) vs BIO-TECHNE Corp (TECH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Reddit Inc vs BIO-TECHNE Corp — how do they compare? Reddit Inc trades at $159.6 (market cap $30.10B), while BIO-TECHNE Corp trades at $72.44 (market cap $11.36B). The key difference: Reddit Inc is far larger — about 2.6× BIO-TECHNE Corp's market cap, and BIO-TECHNE Corp pays a 0.44% dividend while Reddit Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Reddit Inc for 26 Days and BIO-TECHNE Corp for 64 Days on average.
| RDDT | TECH | |
|---|---|---|
Market Cap | $30.10B | $11.36B |
Volume | 4,560,440 | 5,390,331 |
Sector | Media | Health |
52-Week High | $258.93 | $72.61 |
52-Week Low | $121.84 | $43.31 |
Typical Hold Time | 26 Days | 64 Days |
Enterprise Value | $27.34B | $11.39B |
Dividend Yield | — | 0.44% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Reddit (RDDT) trades at $161.53, up 5.73% with strong earnings momentum after beating Q2 2026 EPS estimates. The stock shows bullish technical signals with support at $154 and resistance at $163. Fundamentally, the company maintains exceptional 91.44% gross margins and 31.35% net income margin, with revenue projected to grow from $2.2B to $2.8B in 2026. Recent news highlights international expansion and AI partnerships while facing competitive pressures.
Outlook remains positive with 65.52% analyst buy ratings and $202.52 consensus target, though risks include CEO stock sales and competitive threats. The valuation appears elevated at 36.39 P/E, but strong profitability and growth trajectory support the bullish case for investors seeking social media exposure.
Bio-Techne (TECH) trades at $72.45, down 0.11% on the day, near its 52-week high of $72.70. The stock shows bullish technical signals with strong moving average support. Fundamentally, the company maintains solid gross margins of 65.77% but faces declining net income margins, dropping from 24.6% in 2022 to 6.01% in 2025. Recent shareholder approval of Merck KGaA's acquisition at $73 per share provides a clear near-term catalyst.
The pending acquisition offers limited upside from current levels but provides downside protection. However, declining profitability trends and elevated valuation ratios (P/E 62.46) pose risks if the deal falls through. Investors should weigh the acquisition premium against fundamental deterioration in earnings quality.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Reddit Inc
Reddit Inc. operates a vast network of online communities organized around various interests, known as 'subreddits'. Functioning as a hybrid of a social media platform and a discussion forum, the company generates revenue primarily through advertising and premium subscriptions. Reddit is a major hub for user-generated content, trending news, and viral discussions, and it is a key player in the digital advertising and social media landscape.
Read more on RDDT →About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →
